Tune in today via webcast at 11:30 am Eastern to hear from management, key commercial stakeholders, university officials and ...
Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback